Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics for Persistent H. Pylori Eradication
NCT05674864Unknown
- Sponsor
- Tanta University
- Start
- Jan 2023
- Primary completion
- Aug 2023
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, double-blind trial of Lactobacillus acidophilus + Bifidobacterium infantis + Enterococcus faecium in Helicobacter pylori infection (2 arms), sponsored by Tanta University. Primary endpoint: Eradication of H. Pylori infection. Status: unknown.
02
Drugs
Lactobacillus acidophilus + Bifidobacterium infantis + Enterococcus faecium
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05674864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05674864.